Our mission is to develop and translate noninvasive MR- and PET-based metabolic imaging tools that reveal actionable metabolic vulnerabilities and accelerate the development of new therapies. We integrate rigorous molecular and cellular validation with preclinical animal studies and matched co-clinical trials, advancing promising imaging biomarkers through IND-enabling steps and into patient studies through close partnerships with physician-scientists and industry.
Meet Our Team
Rong Zhou, PhD
Director of TMMI Lab
Hoon Choi
Senior Research Investigator
hoonchoi@seas.upenn.edu
Lab Phone: 215-746-8751
Contact Us
198 John Morgan Building
3620 Hamilton Walk
Phone: (215) 746-8747
Email: rongzhou@pennmedicine.upenn.edu
Catherine Oliva
Administrative Assistant
Phone: (215) 615-9042
Email: Catherine.Oliva@pennmedicine.upenn.edu
In This Section
-
Our lab is focused on projects to develop experimental therapeutic approaches for heart failure and for cancer.
-
Our lab is focused on projects to develop experimental therapeutic approaches for heart failure and for cancer.
-
See a select list of publications from TMMI over the last several years, focusing on the development and application of imaging technologies to study cardiovascular disease and therapy response.
-
Meet alumni of the Metabolic & Molecular Imaging of Cardiovascular Diseases (MMICD) Lab.